Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
Stocks in this Quantisnow insightHealth Care
Historical context for HIMS
Across the 23 sessions after earlier HIMS headlines, the stock closed higher 12 times and lower 11 times, with a median move of 3.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | HIMS | SPY |
|---|---|---|---|
| May 19, 2026 | Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment | +0.7% | -0.7% |
| May 18, 2026 | Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment | -11.0% | -0.1% |
| May 12, 2026 | Needham reiterated coverage on Hims & Hers Health with a new price targetand 1 other headline that session | -14.1% | -0.2% |
| Apr 28, 2026 | Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors | -5.0% | -0.5% |
| Apr 24, 2026 | Analyst initiated coverage on Hims & Hers Health with a new price target | +8.6% | +0.8% |
| Apr 14, 2026 | Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026 | +1.0% | +1.2% |
Quantisnow market dataNYSE
HIMS
Hims & Hers Health Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- Listed since
- 2019
Get push alerts for HIMS
Full HIMS profile on Quantisnow Follow HIMS and get a push notification the moment its next story breaks.